Statistics
Publications
2
Citations
58
H-Index
2
Active since
2019
Affiliations
Kevin Stirling is an author at Stanford University specializing in egfr inhibition, chemotherapy, and medicine.
Publications per year
2019–2021
2
2
Combining Osimertinib With Chemotherapy in EGFR-Mutant NSCLC at Progression
Maya N. White, Zofia Piotrowska, Kevin Stirling et al. · Clinical Lung Cancer · 2021 · 42 citations · Full text
Medicine, Oncology, Pharmacology +11
1–2 of 2